15 results on '"Yi, Shounan"'
Search Results
2. Culturing with modified EGM2 medium enhances porcine neonatal islet-like cell clusters resistance to apoptosis in islet xenotransplantation.
- Author
-
Ma X, Yang C, Zhang J, Wang J, Li W, Xu C, Rong P, Ye B, Wu M, Jiang J, Yi S, and Wang W
- Subjects
- Animals, Animals, Newborn, Cells, Cultured, Diabetes Mellitus immunology, Glucose metabolism, Humans, Insulin metabolism, Islets of Langerhans Transplantation methods, Apoptosis immunology, Heterografts immunology, Islets of Langerhans cytology, Transplantation, Heterologous methods
- Abstract
Background: Neonatal pig islet-like cell clusters (NICC) are an attractive source of insulin-producing tissue for potential transplantation treatment of type 1 diabetic patients. However, a considerable loss of NICC after their transplantation due to apoptosis resulted from islet isolation and instant blood-mediated inflammatory reaction remains to be overcome., Methods: EGM2 medium depleted with hydrocortisone and supplemented with 50 mmol/L isobutylmethylxanthine, 10 mmol/L nicotinamide, and 10 mmol/L glucose was used to culture NICC at day 1, the day after isolation and changed every other day. NICC cultured with EGM2 or control Ham's F-10 medium were collected at day 7 of culture for the following assays. The viability of NICC was evaluated by AO/EB staining and FACS. Static assay and oxygen consumption rate analysis were performed to assess the function of NICC. Insulin and glucagon gene expression were measured by real-time PCR. Tubing loops model and TUNEL assay were performed to confirm the apoptosis-resistant ability of NICC cultured with modified EGM2 medium. Serum starvation and hypoxia treatment were used to test the tolerant capability of NICC in the microenvironment of hypoxia/nutrient deficiency in vitro. The molecules involved in apoptosis pathways in NICC were analyzed by Western blotting., Results: Compared with Ham's F-10 medium, culturing NICC with EGM2 medium led to increased number and viability of NICC with higher stimulation index, upregulated gene expression of both insulin and glucagon, and enhanced mitochondria function. Furthermore, fewer modified EGM2 medium cultured NICC were found under apoptosis when evaluated in an in vitro tubing loop model of IBMIR. Moreover, EGM2 medium cultured NICC demonstrated much less apoptotic cells under either serum starvation or hypoxia condition than their Ham's F-10 medium cultured counterparts. The enhanced capability of EGM2 cultured NICC to resist apoptosis was associated with their elevated protein levels of anti-apoptotic Bcl-2 family member Mcl-1., Conclusion: Culturing NICC with EGM2 provides a simple and effective approach not only to increase NICC yield, viability, and maturation but also to enhance their resistance to apoptosis to preserve the initial graft mass for successful islet xenotransplantation., (© 2017 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.)
- Published
- 2018
- Full Text
- View/download PDF
3. A preclinical evaluation of alternative site for islet allotransplantation.
- Author
-
Wang C, Du X, He S, Yuan Y, Han P, Wang D, Chen Y, Liu J, Tian B, Yang G, Yi S, Gao F, Zhong Z, Li H, Cheng J, and Lu Y
- Subjects
- Animals, Blood Glucose, Bone Marrow Transplantation, C-Peptide blood, Diabetes Mellitus, Experimental pathology, Disease Models, Animal, Glucose Tolerance Test, Graft Survival, Humans, Immunosuppressive Agents administration & dosage, Islets of Langerhans pathology, Liver pathology, Macaca mulatta, Tibia transplantation, Diabetes Mellitus, Experimental therapy, Islets of Langerhans Transplantation, Liver growth & development, Transplantation, Heterologous methods
- Abstract
The bone marrow cavity (BMC) has recently been identified as an alternative site to the liver for islet transplantation. This study aimed to compare the BMC with the liver as an islet allotransplantation site in diabetic monkeys. Diabetes was induced in Rhesus monkeys using streptozocin, and the monkeys were then divided into the following three groups: Group1 (islets transplanted in the liver with immunosuppressant), Group 2 (islets transplanted in the tibial BMC), and Group 3 (islets transplanted in the tibial BMC with immunosuppressant). The C-peptide and blood glucose levels were preoperatively measured. An intravenous glucose tolerance test (IVGTT) was conducted to assess graft function, and complete blood cell counts were performed to assess cell population changes. Cytokine expression was measured using an enzyme-linked immune sorbent assay (ELISA) and MILLIPLEX. Five monkeys in Group 3 exhibited a significantly increased insulin-independent time compared with the other groups (Group 1: 78.2 ± 19.0 days; Group 2: 58.8 ± 17.0 days; Group 3: 189.6 ± 26.2 days) and demonstrated increases in plasma C-peptide 4 months after transplantation. The infusion procedure was not associated with adverse effects. Functional islets in the BMC were observed 225 days after transplantation using the dithizone (DTZ) and insulin/glucagon stains. Our results showed that allogeneic islets transplanted in the BMC of diabetic Rhesus monkeys remained alive and functional for a longer time than those transplanted in the liver. This study was the first successful demonstration of allogeneic islet engraftment in the BMC of non-human primates (NHPs).
- Published
- 2017
- Full Text
- View/download PDF
4. Transplantation of xenogeneic islets: are we there yet?
- Author
-
O'Connell PJ, Cowan PJ, Hawthorne WJ, Yi S, and Lew AM
- Subjects
- Animals, Graft Rejection immunology, Heterografts immunology, Humans, Immunosuppression Therapy, Inflammation pathology, Islets of Langerhans Transplantation, Transplantation, Heterologous
- Abstract
Beta cell replacement therapy has been proposed as a novel therapy for the treatment of type 1 diabetes. The proof of concept has been demonstrated with successful islet allotransplantation. Islet xenotransplantation has been proposed as an alternative, more reliable, and infinite source of beta cells. The advantages of islet xenotransplantation are the ability to transplant a well differentiated cell that is responsive to glucose and the potential for genetic modification which focuses the treatment on the donor rather than the recipient. The major hurdle remains overcoming the severe cellular rejection that affects xenografts. This review will focus on the major advances that have occurred with genetic modification and the successful therapeutic strategies that have been demonstrated in nonhuman primates. Novel approaches to overcome cell-mediated rejection including biological agents that target selectively costimulation molecules, the development of local immunosuppression through genetic manipulation, and encapsulation will be discussed. Overall, there has been considerable progress in all these areas, which eventually should lead to clinical trials.
- Published
- 2013
- Full Text
- View/download PDF
5. A humanized mouse model to study human immune response in xenotransplantation.
- Author
-
Ji M, Jin X, Phillips P, and Yi S
- Subjects
- Animals, Humans, Interleukin Receptor Common gamma Subunit physiology, Islets of Langerhans Transplantation immunology, Mice, Mice, Inbred NOD, Mice, SCID, Models, Animal, Swine, Transplantation, Heterologous immunology
- Abstract
Background: A major barrier to the clinical application of xenotransplantation as a treatment option for patients is T cell-mediated rejection. Studies based on experimental rodent models of xenograft tolerance or rejection in vivo have provided useful information about the role of T cell immune response in xenotransplantation. However not all observations seen in rodents faithfully recapitulate the human situation. This study aimed to establish a humanized mouse model of xenotransplantation, which mimics xenograft rejection in the context of the human immune system., Methods: NOD-SCID IL2rgamma-/- mice were transplanted with neonatal porcine islet cell clusters (NICC) followed by reconstitution of human peripheral blood mononuclear cells (PBMC). Human leukocyte engraftment and islet xenograft rejection were confirmed by flow cytometric and histological analyses., Results: In the absence of human PBMC, porcine NICC transplanted into NOD-SCID IL2rgamma-/- mice revealed excellent graft integrity and endocrine function. Human PBMC demonstrated a high level of engraftment in NOD-SCID IL2rgamma-/- mice. Reconstitution of NICC recipient NOD-SCID IL2rgamma-/- mice with human PBMC led to the rapid destruction of NICC xenografts in a PBMC number-dependent manner., Conclusions: Human PBMC-reconstituted NOD-SCID IL2rgamma-/- mice provide an ideal model to study human immune responses in xenotransplantation. Studies based on this humanized mouse model will provide insight for improving the outcomes of clinical xenotransplantation.
- Published
- 2012
- Full Text
- View/download PDF
6. A clinical trial of xenotransplantation of neonatal pig islets for diabetic patients.
- Author
-
Wang W, Mo Z, Ye B, Hu P, Liu S, and Yi S
- Subjects
- Adolescent, Adult, Animals, Animals, Newborn, C-Peptide blood, Dogs, Female, Follow-Up Studies, Hepatic Artery, Humans, Injections, Intra-Arterial, Male, Mice, Mice, Nude, Middle Aged, Swine, Young Adult, Diabetes Mellitus, Experimental surgery, Diabetes Mellitus, Type 1 surgery, Immunosuppressive Agents therapeutic use, Islets of Langerhans Transplantation methods, Transplantation, Heterologous methods
- Abstract
Objective: To ascertain the safety and function of the transplantation of neonatal pig islets (NPIs) for diabetic patients., Methods: NPIs were injected into the hepatic artery of 22 patients. After the transplantation, the patients were treated with a multiple drug immunosuppressive regimens. The first 14 patients were treated with cyclosporine (CsA), mycophenolate mofetil (MMF) and prednisolon, and porcine C-peptide was not monitored, the following 2 patients were given cyklosporin and MMF only, while the next 6 patients were given a quadruple drug regimen consisting of OKT3, takrolimus, sirolimus and prednisolon. The blood glucose levels,exogenous insulin requirement,HbA1c, porcine endogenous retrovirus (PERV) and liver function were assessed before and after NPI transplantation. The serum porcine C peptide were monitored in last 8 patients., Results: The first 14 patients required less insulin and the HbA1c dropped after the transplantation. In the 2 subsequent patients, the metabolic parameters remained unchanged and monitor of porcine C-peptide was negative. Insulin requirements were reduced in all 6 patients, and HbA1c was normalized 3 months after the transplantation. Significant levels of porcine C-peptide were detected in the patient serum. Two of the patients were given a second injection of NPIs, and one of them became insulin independent for 7 d. No serious adverse events were noted after the transplantation. There was no evidence of PERV transmission. Six out of the 22 patients were followed up for 4-6 years after the NPIs injection, immunosuppressive treatment was stopped 1 year after the transplantation. The patients started to take insulin at the time of follow up. Four patients restricted the intake of sugar, while the other 2 did not. One patient had ketoacidosis twice and slight diabetic retinopathy, and another patient had ketoacidosis induced by acute gastroenteritis. The remaining 4 patients did not have any complications. Assays for PERV were again negative., Conclusion: Xenogenic islets can survive and function in the human body. No serious adverse events are noted.
- Published
- 2011
- Full Text
- View/download PDF
7. Role of regulatory T cells in xenotransplantation.
- Author
-
O'Connell PJ, Yi S, Carrington EM, and Lew AM
- Subjects
- Animals, Graft Rejection prevention & control, Humans, Immunity, Cellular, Immunosuppressive Agents therapeutic use, Species Specificity, T-Lymphocytes, Regulatory drug effects, Graft Rejection immunology, Graft Survival drug effects, T-Lymphocytes, Regulatory immunology, Transplantation Tolerance, Transplantation, Heterologous immunology
- Abstract
Purpose of Review: Although much has been written about the biology of regulatory T cells (Tregs), their characterization and role in xenotransplantation has been limited. This review summarizes the recent literature supporting a role for Tregs in the cell-mediated xenoimmune response., Recent Findings: Studies in in-vitro assays systems have focused on the biology of natural Tregs, whereas in-vivo rodent models of induced tolerance to xenografts have implied an important role for CD4CD8 double-negative T cells. Although it was not unexpected that natural Tregs would have the capacity to modulate the T-cell-mediated response to xenografts, there are features that are different to what is seen in alloimmunity. The Tregs response to pig xenografts is more dependent on immunomodulatory cytokines such as IL-10, whereas in-vitro Tregs function in alloimmunity is focused strongly on cell contact mechanisms. In the acquired immune response, the majority of published findings have highlighted the properties of CD4CD8 double-negative Tregs, whereas little if anything has been written about the more familiar CD4CD25 Tregs, which has been well described with in-vivo models of acquired alloimmune tolerance., Summary: Although many investigators feel there are unique opportunities for using cell-based immunomodulatory therapies in xenotransplantation, our current understanding of the biology of Treg response remains incomplete. These gaps in our understanding need to be overcome before Tregs can be realized therapeutically to modulate the strong cellular xenoimmune response.
- Published
- 2010
- Full Text
- View/download PDF
8. Foxp3 regulates human natural CD4+CD25+ regulatory T-cell-mediated suppression of xenogeneic response.
- Author
-
Sun L, Yi S, and O'Connell PJ
- Subjects
- Animals, Cytokines immunology, Forkhead Transcription Factors genetics, Gene Knockdown Techniques, Humans, Lymphocyte Subsets immunology, RNA, Small Interfering genetics, RNA, Small Interfering metabolism, Swine, CD4-Positive T-Lymphocytes immunology, Forkhead Transcription Factors physiology, Interleukin-2 Receptor alpha Subunit immunology, T-Lymphocytes, Regulatory immunology, Transplantation, Heterologous immunology
- Abstract
Backgrounds: Cellular rejection of xenografts is predominantly mediated by CD4+ T cells. Foxp3 expressing human naturally occurring CD4+CD25+ regulatory T cells (nTregs) have been shown to suppress pathological and physiological immune responses, including the CD4+ T-cell-mediated anti-pig xenogeneic response in vitro. Although Foxp3 is required for nTreg development and their function, the precise role of Foxp3 in regulating Treg suppressive function in xenoimmune response remains to be identified., Methods: In vitro expanded human nTregs were transfected with fluorescein isothiocyanate -conjugated Foxp3 small interfering RNA (siRNA) by Lipofectamine 2000. Transfected nTregs were sorted by fluorescence-activated cell sorting, and then analyzed for Foxp3 gene and protein expression as well as their phenotypic characteristics. Human CD4+CD25- T cells were stimulated with xenogeneic pig peripheral blood mononuclear cell in the presence or absence of nTregs in a coculture or transwell system for evaluation of nTreg suppressive activity. The production of effector cytokines by xenoreactive CD4+CD25- T cells as well as suppressive cytokine by nTregs in their cocultures was examined by ELISA., Results: The siRNA-mediated Foxp3 knockdown resulted in impaired nTreg anergic state, downregulated expression of nTreg function associated molecules, and reduced production of suppressive cytokines by nTregs, which together leading to impaired nTreg-mediated suppression of CD4+CD25- T-cell proliferation and their effector cytokine production in response to xenogeneic stimulation., Conclusions: This study demonstrates that Foxp3 expression is required for human nTregs to maintain their suppressive function in the xenoimmune response.
- Published
- 2010
- Full Text
- View/download PDF
9. In vitro suppression of xenoimmune-mediated macrophage activation by human CD4+CD25+ regulatory T cells.
- Author
-
Fu Y, Yi S, Wu J, Jimenez E, Simond D, Hawthorne WJ, and O'Connell PJ
- Subjects
- Antibodies, Monoclonal immunology, Antigen-Presenting Cells immunology, Antigens, Heterophile immunology, CD4 Antigens immunology, Cell Survival, Humans, Interleukin-2 Receptor alpha Subunit immunology, Lymphocyte Activation immunology, T-Lymphocytes, Regulatory cytology, Macrophage Activation immunology, T-Lymphocytes, Regulatory immunology, Transplantation, Heterologous immunology
- Abstract
Background: Macrophages are important effector cells in T cell-mediated xenograft rejection. The aim of this study was to determine whether CD4+CD25+ regulatory T cells (Tregs) were capable of suppressing macrophage activation in vitro., Methods: Porcine cell or xenoantigen-primed human peripheral blood mononuclear cells, CD4+ T cell-depleted peripheral blood mononuclear cells, or CD14+ macrophages plus autologous CD4+CD25- T cells were cultured with or without expanded autologous Tregs. Transwell cultures were used to separate the various components to determine the need for cell-cell contact., Results: Pig cell primed CD14+ macrophages required the presence of CD4+CD25- T cells for activation and increased expression of CD40, interleukin-12, and tumor necrosis factor-alpha. This up-regulated expression of macrophage activation markers was reduced substantially in the presence of autologous Tregs. Coculture with Tregs did not alter macrophage viability but reduced the capacity of macrophages to stimulate proliferation of responder T cells. Tregs required direct contact with CD4+CD25- T cells to inhibit macrophage activation but activated macrophage phenotype was not altered by separating the stimulated human peripheral blood mononuclear cells or CD14+ macrophages from Tregs in a transwell system. Macrophages did not require direct cell contact with porcine stimulator cells for full activation by CD4+CD25- T cells., Conclusions: Human Tregs were able to suppress xenoantigen-primed and CD4+ T-cell-mediated macrophage activation and antigen-presenting cell function. However, Tregs had no direct effect on macrophages in vitro.
- Published
- 2008
- Full Text
- View/download PDF
10. Selective rejection of porcine islet xenografts by macrophages.
- Author
-
Fu Y, Lu X, Yi S, Wu J, O'Hara JM, Hawthorne WJ, Hucker K, and O'Connell PJ
- Subjects
- Animals, Blood Glucose immunology, Female, Graft Rejection blood, Graft Rejection pathology, Islets of Langerhans Transplantation pathology, Macrophage Activation immunology, Male, Mice, Transplantation, Homologous immunology, Graft Rejection immunology, Islets of Langerhans Transplantation adverse effects, Islets of Langerhans Transplantation immunology, Macrophages immunology, Swine immunology, Transplantation, Heterologous immunology
- Abstract
Background: Our previous study has shown that porcine antigen-primed and CD4+ T cell-activated macrophages are capable of recognition and rejection of porcine xenografts after adoptive transfer. However, whether this is an absolute xenograft specific rejection remains to be confirmed., Methods: Mouse islet allografts and neonatal porcine islet cell cluster (NICC) xenografts were admixed and transplanted under the left kidney capsule, and NICC xenografts alone were transplanted under the right kidney capsule of strepotozotocin-induced diabetic NOD-SCID mice. After achievement of normoglycemia, the NOD-SCID recipients were transferred with macrophages purified from NICC transplant NOD-SCID mice reconstituted with CD4+ T cells. Five weeks after macrophage transfer the left kidney with the admixed grafts were removed. Graft survival and function following macrophage transfer was assessed by blood glucose measurement and immunohistochemistry., Results and Conclusions: Adoptive transfer with activated macrophages did not affect the normalized blood glucose levels in NOD-SCID recipients of admixed grafts until left nephrectomy 5 weeks post-macrophage transfer. Insulin-positive and porcine C-peptide-negative mouse islets were detected in the admixed grafts. The surviving mouse islets in the admixed grafts were surrounded but not infiltrated by macrophages. The nephrectomized recipients demonstrated sustained hyperglycemia and completely destroyed NICC xenografts in their remaining right kidneys 8 weeks after macrophage transfer. Taken together, these data provide direct evidence of porcine islet xenograft specific rejection by activated macrophages.
- Published
- 2008
- Full Text
- View/download PDF
11. Requirement of MyD88 for macrophage-mediated islet xenograft rejection after adoptive transfer.
- Author
-
Yi S, Wang Y, Chandra AP, O'Hara JM, Wu J, Ouyang L, Burgess JS, Hawthorne W, Wu H, Chadban SJ, and O'Connell PJ
- Subjects
- Animals, Female, Flow Cytometry, Gene Expression Regulation, Islets of Langerhans Transplantation immunology, Islets of Langerhans Transplantation pathology, Macrophage Activation, Male, Mice, Mice, Inbred C57BL, Mice, Knockout, Myeloid Differentiation Factor 88 deficiency, Myeloid Differentiation Factor 88 genetics, Polymerase Chain Reaction, Swine, Toll-Like Receptors physiology, Adoptive Transfer, Graft Rejection immunology, Islets of Langerhans Transplantation physiology, Macrophages immunology, Myeloid Differentiation Factor 88 physiology, Transplantation, Heterologous pathology
- Abstract
Background: Porcine antigen primed and CD4+ T-cell activated macrophages are able to migrate to and destroy porcine xenografts. However, the specific signaling mechanisms involved remain to be identified., Methods: In this study macrophages which lack the universal toll-like receptor (TLR) adaptor MyD88 were used to investigate the role of TLR in the recognition and activation of macrophages in islet xenograft rejection. Macrophages were isolated from rejecting MyD88(-/-) and wild-type C57BL/6 mice that were recipients of neonatal porcine pancreatic cell cluster (NPCC) xenografts, and were transferred to NPCC recipient NOD-SCID mice., Results: Both wild-type C57BL/6 and MyD88(-/-) mice rejected NPCC xenografts 8 and 10 days, respectively after transplantation, and the grafts were heavily infiltrated with CD4+ T cells and macrophages. However, graft infiltrating macrophages from rejecting MyD88(-/-) recipients demonstrated impaired up-regulation of TLR expression and impaired activation phenotype, when compared to those from rejecting C57BL/6 recipients. Transfer of NOD-SCID recipients with macrophages from rejecting C57BL/6 mice resulted in NPCC xenograft rejection along with massively infiltrated macrophages 8 days after transfer, whereas NPCC xenografts in NOD-SCID mice transferred with macrophages from rejecting MyD88(-/-) mice remained intact until the end of this study, 90 days after transfer, with insulin-positive islets and no infiltration by macrophages., Conclusion: This study demonstrates that deletion of MyD88 causes impaired macrophage activation after pig islet xenotransplantation. However, graft survival is not prolonged and xenografts are rejected rapidly by alternate mechanisms.
- Published
- 2007
- Full Text
- View/download PDF
12. Chemokine and toll-like receptor signaling in macrophage mediated islet xenograft rejection.
- Author
-
Chandra AP, Ouyang L, Yi S, Wong JK, Ha H, Walters SN, Patel AT, Stokes R, Jardine M, Hawthorne WJ, and O'Connell PJ
- Subjects
- Animals, CD4-Positive T-Lymphocytes immunology, Cell Movement, Chemokines immunology, Female, Gene Expression, Graft Rejection metabolism, Islets of Langerhans Transplantation adverse effects, Islets of Langerhans Transplantation pathology, Macrophages cytology, Macrophages metabolism, Mice, Receptors, CCR2, Receptors, CCR5 genetics, Receptors, CCR5 immunology, Receptors, Chemokine genetics, Receptors, Chemokine immunology, Skin immunology, Skin metabolism, Swine, Toll-Like Receptors genetics, Up-Regulation, Chemokines metabolism, Graft Rejection immunology, Islets of Langerhans Transplantation immunology, Macrophages immunology, Signal Transduction immunology, Toll-Like Receptors metabolism, Transplantation, Heterologous immunology
- Abstract
Background: Adoptive transfer of antigen-primed T-cell-activated macrophages into NOD-SCID mice within 14 days of foetal porcine pancreatic fragment (FPP) or foetal porcine skin (FPS) transplantation had been shown to cause xenograft rejection. In the present study, it was proposed that signaling between the graft and macrophages promoted specific graft recognition and destruction in this setting., Methods: Exogenous macrophages isolated from rejecting FPP xenografts were transferred to NOD-SCID FPP recipients and tracked by Ly5.1 surface antigen or via CSFE staining. Monocyte chemoattractant protein-1 (MCP-1), macrophage inflammatory protein-1alpha (MIP-1alpha), macrophage inflammatory protein-1beta (MIP-1beta), regulated upon activation, normal T-cell expressed and secreted (RANTES), chemokine (C-C motif) receptor 2 (CCR2), chemokine (C-C motif) receptor 5 (CCR5), toll-like receptors (TLRs) (1-9) and gene expression in transplanted FPP xenografts was evaluated by real-time polymerase chain reaction. Gene expression of CCR2, CCR5 and TLRs was also analyzed in pooled samples of activated and non-activated macrophages., Results: Exogenous macrophages were shown to track to and reject recently transplanted but not established FPP xenografts. Gene expression for MCP-1, RANTES, MIP-1alpha and MIP-1beta was at least 3-fold greater in recently transplanted compared with established xenografts (P < 0.05), and CCR2 and CCR5 gene expression was 10-fold greater in activated compared non-activated macrophages, suggesting that graft-mediated pro-inflammatory signals were important for macrophage recruitment. Specific graft recognition by macrophages may involve TLR signaling as macrophages exposed to porcine islets had higher levels of TLR gene expression compared with those exposed to allografts regardless of the level of activation., Conclusion: Xenografts provide additional activation signals to macrophages that are not seen following allotransplantation. This study identifies chemokines and TLR as important signals in macrophage-mediated recognition and rejection of islet xenografts.
- Published
- 2007
- Full Text
- View/download PDF
13. T cell-activated macrophages are capable of both recognition and rejection of pancreatic islet xenografts.
- Author
-
Yi S, Hawthorne WJ, Lehnert AM, Ha H, Wong JK, van Rooijen N, Davey K, Patel AT, Walters SN, Chandra A, and O'Connell PJ
- Subjects
- Adoptive Transfer, Animals, Biomarkers analysis, CD4-Positive T-Lymphocytes transplantation, Cell Movement immunology, Cytotoxicity, Immunologic, Female, Fetal Tissue Transplantation immunology, Fetal Tissue Transplantation pathology, Graft Rejection pathology, Immunophenotyping, Islets of Langerhans Transplantation pathology, Macrophages metabolism, Macrophages pathology, Macrophages transplantation, Male, Mice, Mice, Inbred BALB C, Mice, Inbred NOD, Mice, SCID, Signal Transduction immunology, Swine, Transplantation Conditioning, Transplantation, Heterologous pathology, Graft Rejection immunology, Islets of Langerhans Transplantation immunology, Macrophage Activation immunology, Macrophages immunology, T-Lymphocyte Subsets immunology, Transplantation, Heterologous immunology
- Abstract
Macrophages have been proposed as the major effector cell in T cell-mediated xenograft rejection. To determine their role in this response, NOD-SCID mice were transplanted with fetal pig pancreas (FPP) before reconstitution with CD4(+) T cells from BALB/c mice. Twelve days after CD4(+) T cell reconstitution, purified macrophages (depleted of T cells) were isolated from CD4(+) T cell-reconstituted FPP recipient mice and adoptively transferred to their nonreconstituted counterparts. After adoptive macrophage transfer, FPP recipient mice transferred with macrophages from CD4(+) T cell-reconstituted mice demonstrated xenograft destruction along with massive macrophage infiltration at day 4 and complete graft destruction at day 8 postmacrophage transfer. By contrast, FPP recipients that received macrophages from nonreconstituted mice showed intact FPP xenografts with few infiltrating macrophages at both days 4 and 8 after macrophage transfer. The graft-infiltrating macrophages showed increased expression of their activation markers. Depletion of endogenous macrophages or any remaining CD4(+) T cells did not delay graft rejection in the macrophage-transferred FPP recipients, whereas depletion of transferred macrophages with clodronate liposomes prevented graft rejection. Our results show that macrophages primed by FPP and activated by CD4(+) T cells were attracted from the peripheral circulation and were capable of specific targeting and destruction of FPP xenografts. This suggests that in xenograft rejection, there are macrophage-specific recognition and targeting signals that are independent of those received by T cells.
- Published
- 2003
- Full Text
- View/download PDF
14. IFN-gamma but not IL-4 is important for mouse CD4+ T cell-mediated macrophage activation following their exposure to pig cells in vitro.
- Author
-
Yi S and O'Connell PJ
- Subjects
- Animals, Antibody Formation, Cell Membrane immunology, Cells, Cultured, Cytokines analysis, DNA Primers, Fetal Tissue Transplantation immunology, Flow Cytometry, Macrophage Activation drug effects, Male, Mice, Mice, Inbred C57BL, Reverse Transcriptase Polymerase Chain Reaction, Swine, CD4-Positive T-Lymphocytes immunology, Interferon-gamma genetics, Interferon-gamma pharmacology, Interleukin-4 genetics, Macrophage Activation immunology, Transplantation, Heterologous immunology
- Abstract
In order to investigate the mechanism by which CD4+ T cells and macrophages interact in the xenogeneic immune response, murine CD4+ T cells and macrophages were used as responder cells in culture with irradiated fetal pig spleen cells (FPSC) as pig xenogeneic stimulators. In this in vitro model, murine CD4+ T cells and macrophages were cultured individually, or together with FPSC. In addition, mouse CD4+ T cells were also cultured with autologous macrophages which were previously stimulated by FPSC. The cultured murine cells were analyzed for expression of CD4+ T cell and macrophage activation markers (cell surface markers and cytokines) as well as cytokine production. CD4+ T cells and macrophages cultured alone or together without FPSC showed unchanged low levels of expression of activation markers. Coculture of macrophages with FPSC and in the absence of CD4+ T cells induced increased expression levels of all the activation markers examined except B7.2 and ICAM-1. Addition of CD4+ T cells to the coculture further enhanced this up-regulation. Coculture of CD4+ T cells with FPSC-stimulated macrophages, but not naive macrophages, or FPSC alone, resulted in significantly increased numbers of CD4+ T cells coexpressing their activation markers, especially IFN-gamma and CD40L, and this expression was enhanced further by including FPSC in the coculture. The activation of both CD4+ T cells and macrophages in their coculture with FPSC was suppressed by neutralizing IFN-gamma but not IL-4. Our results demonstrated that interaction of CD4+ T cells and autologous macrophages was required for their optimal activation in response to pig xenogeneic stimulation. The mechanisms involved included cell-cell and/or cytokine interactions, and in particular IFN-gamma mediated communication was involved. Macrophages activated by pig cells in the absence of CD4+ T cells were able to activate naive CD4+ T cells, thus providing an important communication pathway between innate immune activation and a T cell mediated response in xenograft rejection.
- Published
- 2002
- Full Text
- View/download PDF
15. CD4+ T cells initiate pancreatic islet xenograft rejection via an interferon-gamma-dependent recruitment of macrophages and natural killer cells.
- Author
-
Yi S, Feng X, Hawthorne WJ, Patel AT, Walters SN, and O'Connell PJ
- Subjects
- Animals, Female, Fetal Tissue Transplantation, Lymphocyte Activation, Macrophage Activation, Male, Membrane Glycoproteins physiology, Mice, Mice, Inbred BALB C, Mice, SCID, Perforin, Pore Forming Cytotoxic Proteins, Swine, CD4-Positive T-Lymphocytes immunology, Graft Rejection etiology, Interferon-gamma physiology, Islets of Langerhans Transplantation immunology, Killer Cells, Natural immunology, Macrophages immunology, Transplantation, Heterologous immunology
- Abstract
Background: In this study, the mechanisms by which CD4+ T cells interact with the innate immune system in xenograft rejection were investigated., Methods: Fetal pig pancreas (FPP) grafts were transplanted into female SCID mice. The FPP recipient SCID mice were reconstituted with exogenous leukocytes obtained from male BALB/c mice., Results: Although nonreconstituted SCID recipients or recipients reconstituted with CD4+ T cell-depleted leukocytes showed indefinite FPP graft survival with very few macrophages infiltrating their grafts, reconstitution of SCID recipients with as few as 2x10(5) CD4+ T cells was sufficient to induce rapid xenograft rejection. CD4+ T cells secreted interferon-gamma but not interleukin-4 and initiated the activation and accumulation of macrophages and natural killer cells, that were responsible for the rapid graft destruction. Suppression of interferon-gamma prolonged graft survival and suppressed the macrophages and natural killer cell accumulation and activation., Conclusions: These results demonstrate that CD4+ T cell-dependent cellular xenograft rejection was a result of macrophage and natural killer cell accumulation and activation, but was not mediated by eosinophils. Consistent with this was the finding that interferon-gamma but not interleukin-4 was in part responsible for mediating this effect.
- Published
- 2002
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.